Susan Bobulsky joined the Felton Board of Directors in June 2018. Ms. Bobulsky also serves on the Board’s Development Committee.
Ms. Bobulsky is an accomplished leader with 15 years of experience in commercialization strategy, planning and operations for biotechnology and diagnostic products. She is currently the Vice President, Commercialization for Adaptive Biotechnologies; a biotech company pioneering the use of immunosequencing to advance novel cancer diagnostics and therapeutics. Her previous professional experience spans management consulting, for-profit and not-for-profit healthcare industry organizations. Ms. Bobulsky’s personal interest in Felton’s mission links back to her time as an undergraduate, where she wrote her thesis on technology adoption among health care safety net providers. Her subsequent exposure to the health care challenges faced by vulnerable populations through her career in the biotech industry as well as volunteer work and internships in the nonprofit sector led to her desire to support the Felton Institute’s important work.
Ms. Bobulsky has a Master’s of Business Administration from Stanford Graduate School of Business, and a Bachelor of Science with Honors in Science, Technology and Society from Stanford University.